Brenda Mann, VP of Research & Development at EYEGATE PHARMACEUTICALS INC (EYEG), sold 38,098 shares at $0.24 ($9K) on 2019-07-11, disclosed to the SEC on 2019-07-15.
Open-market sale of $9k EYEG by VP of Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.24 | 6,349 | $2K | 16.9% |
| 2 | $0.24 | 6,349 | $2K | 17.0% |
| 3 | $0.24 | 6,350 | $1K | 16.6% |
| 4 | $0.24 | 6,350 | $2K | 16.9% |
| 5 | $0.23 | 6,350 | $1K | 16.2% |
| 6 | $0.23 | 6,350 |
| $1K |
| 16.4% |
| Total | $0.24 avg | 38,098 | $9K | 100% |